Health & Medicine

STAT+: Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy

31 sec read12 views0 listens

Azalea Therapeutics has demonstrated early success in creating CAR-T cells directly within a patient's body (in vivo) by editing genes in mice, effectively clearing both solid and blood tumors. This method, distinct from traditional CAR-T cell therapy, promises to simplify the treatment process while minimizing risks associated with genetic editing errors. For content creators, this advancement highlights a significant shift towards more efficient and safer cancer treatments that could be a key focus area for future health-related content.

Read the full article at STAT News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Gaming8 hours ago56 sec read

Everything Coming to Amazon Prime Video in September

Based on the provided content, here are some key points and highlights: Prime Video Library Highlights: Prime Video offers a diverse range of movies and TV shows. Notable titles include "The Silence of the Lambs," "Once Upon a Time... In Hollywood,"...

Ali Nemati

Tech & Gadgets10 hours ago25 sec read

How Toronto is using Clariti's AI to speed up building permit approvals

Toronto has launched a one-year pilot program with Clariti's CivCheck AI software to expedite the city's building permit approval process. This initiative aims to reduce delays caused by incomplete applications, which can add significant costs for de...

Ali Nemati

Legal & Policy13 hours ago30 sec read

The Mail-In Ballot Fight Is Right Back Where It Started, With The Trump Administration Taking Another 'L'

A U.S. district court has granted a temporary restraining order against a new USPS rule requiring states to submit ballot-envelope designs for federal approval, halting implementation of the regulation ahead of the November election. This decision is...

Ali Nemati